New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 27, 2013
14:39 EDTRPRXRepros Therapeutics trial information posted to government site
Information regarding a "Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62%" was updated Nov. 20 and processed on Nov. 26, according to clinicaltrials.gov. Reference Link
News For RPRX From The Last 14 Days
Check below for free stories on RPRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for RPRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use